Importantly, gastrointestinal adverse events (nausea, vomiting, diarrhoea) occurred in 3045% of participants during dose escalation but typically resolved within 48 weeks
NA is very active in the gastrointestinal tract (presumably because of gut microflora) [27], suggesting that there might be significant NAM to NA conversion in the intestines
Anticancer bioactive peptide3 inhibits human gastric cancer growth by suppressing gastric cancer stem cells
How does GHK-Cu therapy work
doi: 10.1016/S0928-4257(97)89478-8
Neuropsychopharmacology 39:17771785 Hashimoto R, Nagatsu T, Ohta T, Mizutani M, Omura I (2004) Changes in the concentrations of tetrahydrobiopterin, the cofactor of tyrosine hydroxylase, in blood under physical stress and in depression